Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Azienda Ospedaliero-Universitaria di Parma
Baylor College of Medicine
University Health Network, Toronto
Pierre Fabre Medicament
Mayo Clinic
National Institutes of Health Clinical Center (CC)
AbbVie
Cancer Research UK
AVM Biotechnology Inc
Kelonia Therapeutics, Inc.
Barbara Ann Karmanos Cancer Institute
Novartis
Shenzhen University General Hospital
University Hospital Muenster
AO GENERIUM